248 related articles for article (PubMed ID: 12960522)
1. Update on non-acquired immunodeficiency syndrome-defining malignancies.
Chiao EY; Krown SE
Curr Opin Oncol; 2003 Sep; 15(5):389-97. PubMed ID: 12960522
[TBL] [Abstract][Full Text] [Related]
2. HIV-related Malignancies and Mimics: Imaging Findings and Management.
Javadi S; Menias CO; Karbasian N; Shaaban A; Shah K; Osman A; Jensen CT; Lubner MG; Gaballah AH; Elsayes KM
Radiographics; 2018; 38(7):2051-2068. PubMed ID: 30339518
[TBL] [Abstract][Full Text] [Related]
3. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation of HIV, AIDS, and AIDS-related malignancies.
Verma M
Methods Mol Biol; 2015; 1238():381-403. PubMed ID: 25421672
[TBL] [Abstract][Full Text] [Related]
5. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
[TBL] [Abstract][Full Text] [Related]
6. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
Cheung MC; Pantanowitz L; Dezube BJ
Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
[TBL] [Abstract][Full Text] [Related]
7. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
[TBL] [Abstract][Full Text] [Related]
8. Cancer risk in people infected with human immunodeficiency virus in the United States.
Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
[TBL] [Abstract][Full Text] [Related]
9. [HIV infection and non-AIDS-defining malignancies: an outpatient clinic experience].
Fevereiro Mdo C
Acta Med Port; 2014; 27(2):181-90. PubMed ID: 24813485
[TBL] [Abstract][Full Text] [Related]
10. AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era.
Silverberg MJ; Abrams DI
Curr Opin Oncol; 2007 Sep; 19(5):446-51. PubMed ID: 17762569
[TBL] [Abstract][Full Text] [Related]
11. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P
Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829
[TBL] [Abstract][Full Text] [Related]
12. AIDS-Associated Malignancies.
Vangipuram R; Tyring SK
Cancer Treat Res; 2019; 177():1-21. PubMed ID: 30523619
[TBL] [Abstract][Full Text] [Related]
13. HIV infection and cancer in the era of highly active antiretroviral therapy (Review).
Barbaro G; Barbarini G
Oncol Rep; 2007 May; 17(5):1121-6. PubMed ID: 17390054
[TBL] [Abstract][Full Text] [Related]
14. Non-AIDS-defining cancers: should antiretroviral therapy be initiated earlier?
Cinti SK; Gandhi T; Riddell J
AIDS Read; 2008 Jan; 18(1):18-20, 26-32. PubMed ID: 18240449
[TBL] [Abstract][Full Text] [Related]
15. Overview of cancer incidence and mortality among people living with HIV/AIDS in British Columbia, Canada: Implications for HAART use and NADM development.
Chiu CG; Smith D; Salters KA; Zhang W; Kanters S; Milan D; Montaner JSG; Coldman A; Hogg RS; Wiseman SM
BMC Cancer; 2017 Apr; 17(1):270. PubMed ID: 28410587
[TBL] [Abstract][Full Text] [Related]
16. AIDS malignancies.
Arora A; Chiao E; Tyring SK
Cancer Treat Res; 2007; 133():21-67. PubMed ID: 17672037
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic approaches to AIDS-related malignancies.
Berretta M; Cinelli R; Martellotta F; Spina M; Vaccher E; Tirelli U
Oncogene; 2003 Sep; 22(42):6646-59. PubMed ID: 14528290
[TBL] [Abstract][Full Text] [Related]
18. Evolving epidemiology of malignancies in HIV.
Bonnet F; Chêne G
Curr Opin Oncol; 2008 Sep; 20(5):534-40. PubMed ID: 19106656
[TBL] [Abstract][Full Text] [Related]
19. Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review.
Cobucci RN; Lima PH; de Souza PC; Costa VV; Cornetta Mda C; Fernandes JV; Gonçalves AK
J Infect Public Health; 2015; 8(1):1-10. PubMed ID: 25294086
[TBL] [Abstract][Full Text] [Related]
20. Cancer survival in patients with HIV/AIDS in the era of highly active antiretroviral therapy in Taiwan: a population-based cohort study.
Lin CS; Lin C; Weng SF; Lin SW; Lin YS
Cancer Epidemiol; 2013 Oct; 37(5):719-24. PubMed ID: 23770024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]